CellWell record HH-584287
[Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study]
G Wagner; E Gitsch; L Havelec; W Knapp; H Rainer; S Selander
1983
In plain language
In a double-blind randomized trial of 60 patients with invasive cervical cancer after surgery and radiation, transfer factor immunotherapy was linked to fewer recurrences than placebo (5 of 31 vs 11 of 28).
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-584287
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.